drugset
drugset / Trial / NCT01698944

Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency

NCT01698944 ↗

Phase 4 Terminated 7 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to investigate the effect of growth hormone on left ventricle morphology and function (systolic and diastolic).

Timeline

Start
2001-05-16
Primary completion
2002-11-18
Completion
2002-11-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 3 iu Subcutaneous

Indications

pituitary deficiency